Fred Alger Management »

Nurix Therapeutics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $794k 38k 20.87
2022-06-30 $93k 7.3k 12.73

More positions owned by Fred Alger Management

Microsoft Corp Common (MSFT)
Nvidia Corp. Common (NVDA)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Inc Class A Common (META)
Natera Common (NTRA)
Alphabet Inc Cl C Common (GOOG)
Broadcom Common (AVGO)
Taiwan Semiconductor Common (TSM)
Netflix Common (NFLX)
Visa Inc Class A Shares Common (V)
Applovin Corp Class A Common (APP)
Eli Lilly & Co Common (LLY)
Pinterest Inc Class A Common (PINS)
Gfl Environmental Common (GFL)

View all positions for Fred Alger Management

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Deep Track Capital
Baker Bros. Advisors
Vanguard Group
T. Rowe Price Associates
State Street Corporation
ARK Investment Management
T. Rowe Price Investment Management
Soleus Capital Management
Morgan Stanley
Geode Capital Management
Driehaus Capital Management
Candriam Luxembourg S.C.A.
Citadel Advisors

View all funds holding Nurix Therapeutics